Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 14 entries
Sorted by: Best Match Show Resources per page
Colorectal cancer patients in a tertiary hospital in Indonesia: Prevalence of the younger population and associated factors.

World journal of clinical cases

Makmun D, Simadibrata M, Abdullah M, Syam AF, Shatri H, Fauzi A, Renaldi K, Maulahela H, Utari AP, Pribadi RR, Muzellina VN, Nursyirwan SA.
PMID: 34877319
World J Clin Cases. 2021 Nov 16;9(32):9804-9814. doi: 10.12998/wjcc.v9.i32.9804.

BACKGROUND: An increasing trend in colorectal cancer (CRC) occurring at younger ages has been observed worldwide, even though incidence is declining in the general population. Most currently available guidelines still recommend CRC screening for older populations, despite an alarming...

Cite
Makmun D, Simadibrata M, Abdullah M, et al. Colorectal cancer patients in a tertiary hospital in Indonesia: Prevalence of the younger population and associated factors. World J Clin Cases. 2021;9(32):9804-9814doi: 10.12998/wjcc.v9.i32.9804.
Makmun, D., Simadibrata, M., Abdullah, M., Syam, A. F., Shatri, H., Fauzi, A., Renaldi, K., Maulahela, H., Utari, A. P., Pribadi, R. R., Muzellina, V. N., & Nursyirwan, S. A. (2021). Colorectal cancer patients in a tertiary hospital in Indonesia: Prevalence of the younger population and associated factors. World journal of clinical cases, 9(32), 9804-9814. https://doi.org/10.12998/wjcc.v9.i32.9804
Makmun, Dadang, et al. "Colorectal cancer patients in a tertiary hospital in Indonesia: Prevalence of the younger population and associated factors." World journal of clinical cases vol. 9,32 (2021): 9804-9814. doi: https://doi.org/10.12998/wjcc.v9.i32.9804
Makmun D, Simadibrata M, Abdullah M, Syam AF, Shatri H, Fauzi A, Renaldi K, Maulahela H, Utari AP, Pribadi RR, Muzellina VN, Nursyirwan SA. Colorectal cancer patients in a tertiary hospital in Indonesia: Prevalence of the younger population and associated factors. World J Clin Cases. 2021 Nov 16;9(32):9804-9814. doi: 10.12998/wjcc.v9.i32.9804. PMID: 34877319; PMCID: PMC8610908.
Copy Download .nbib Format: NLM
Differences in the Insulin Resistance Levels Measured by HOMA-IR between Patients with Erosive and Non-Erosive Gastroesophageal Reflux Disease.

Journal of the ASEAN Federation of Endocrine Societies

Budiyani L, Purnamasari D, Simadibrata M, Abdullah M.
PMID: 33442097
J ASEAN Fed Endocr Soc. 2017;32(2):139-144. doi: 10.15605/jafes.032.02.07. Epub 2017 Sep 07.

BACKGROUND: Insulin resistance is the core of Metabolic Syndrome which carries a high risk for cardiovascular events. Insulin resistance had been reported to be higher in GERD patients than subjects without GERD, specifically in erosive esophagitis. Objective. To compare...

Cite
Budiyani L, Purnamasari D, Simadibrata M, et al. Differences in the Insulin Resistance Levels Measured by HOMA-IR between Patients with Erosive and Non-Erosive Gastroesophageal Reflux Disease. J ASEAN Fed Endocr Soc. 2017;32(2):139-144doi: 10.15605/jafes.032.02.07.
Budiyani, L., Purnamasari, D., Simadibrata, M., & Abdullah, M. (2017). Differences in the Insulin Resistance Levels Measured by HOMA-IR between Patients with Erosive and Non-Erosive Gastroesophageal Reflux Disease. Journal of the ASEAN Federation of Endocrine Societies, 32(2), 139-144. https://doi.org/10.15605/jafes.032.02.07
Budiyani, Laras, et al. "Differences in the Insulin Resistance Levels Measured by HOMA-IR between Patients with Erosive and Non-Erosive Gastroesophageal Reflux Disease." Journal of the ASEAN Federation of Endocrine Societies vol. 32,2 (2017): 139-144. doi: https://doi.org/10.15605/jafes.032.02.07
Budiyani L, Purnamasari D, Simadibrata M, Abdullah M. Differences in the Insulin Resistance Levels Measured by HOMA-IR between Patients with Erosive and Non-Erosive Gastroesophageal Reflux Disease. J ASEAN Fed Endocr Soc. 2017;32(2):139-144. doi: 10.15605/jafes.032.02.07. Epub 2017 Sep 07. PMID: 33442097; PMCID: PMC7784086.
Copy Download .nbib Format: NLM
Correlation of gut Firmicutes/Bacteroidetes ratio with fibrosis and steatosis stratified by body mass index in patients with non-alcoholic fatty liver disease.

Bioscience of microbiota, food and health

Jasirwan COM, Muradi A, Hasan I, Simadibrata M, Rinaldi I.
PMID: 33520569
Biosci Microbiota Food Health. 2021;40(1):50-58. doi: 10.12938/bmfh.2020-046. Epub 2020 Sep 15.

We investigated the gut microbiota in patients with non-alcoholic fatty liver disease (NAFLD) and its correlation with fibrosis and steatosis stratified by body mass index, as reflected in the controlled attenuation parameter and transient elastography values. A cross-sectional study...

Cite
Jasirwan COM, Muradi A, Hasan I, et al. Correlation of gut Firmicutes/Bacteroidetes ratio with fibrosis and steatosis stratified by body mass index in patients with non-alcoholic fatty liver disease. Biosci Microbiota Food Health. 2020;40(1):50-58doi: 10.12938/bmfh.2020-046.
Jasirwan, C. O. M., Muradi, A., Hasan, I., Simadibrata, M., & Rinaldi, I. (2021). Correlation of gut Firmicutes/Bacteroidetes ratio with fibrosis and steatosis stratified by body mass index in patients with non-alcoholic fatty liver disease. Bioscience of microbiota, food and health, 40(1), 50-58. https://doi.org/10.12938/bmfh.2020-046
Jasirwan, Chyntia Olivia Maurine, et al. "Correlation of gut Firmicutes/Bacteroidetes ratio with fibrosis and steatosis stratified by body mass index in patients with non-alcoholic fatty liver disease." Bioscience of microbiota, food and health vol. 40,1 (2021): 50-58. doi: https://doi.org/10.12938/bmfh.2020-046
Jasirwan COM, Muradi A, Hasan I, Simadibrata M, Rinaldi I. Correlation of gut Firmicutes/Bacteroidetes ratio with fibrosis and steatosis stratified by body mass index in patients with non-alcoholic fatty liver disease. Biosci Microbiota Food Health. 2021;40(1):50-58. doi: 10.12938/bmfh.2020-046. Epub 2020 Sep 15. PMID: 33520569; PMCID: PMC7817510.
Copy Download .nbib Format: NLM
Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic.

JGH open : an open access journal of gastroenterology and hepatology

Ling KL, Hilmi I, Raja Ali RA, Leong RWL, Leung WK, Ng SC, Wu KC, Chen MH, Ran ZH, Hisamatsu T, Ahuja V, Makharia GK, Banerjee R, Wei SC, Wu DC, Pisespongsa P, Ye BD, Sollano J, Simadibrata M, Chuah SW, Ooi CJ.
PMID: 32514431
JGH Open. 2020 Jun 05;4(3):320-323. doi: 10.1002/jgh3.12362. eCollection 2020 Jun.

The COVID-19 pandemic, secondary to SARS-CoV-2, has resulted in high mortality and morbidity worldwide. As inflammatory bowel disease (IBD) is a chronic disease, and most patients are on long-term immunosuppressive agents, there is understandable concern, particularly in terms of...

Cite
Ling KL, Hilmi I, Raja Ali RA, et al. Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic. JGH Open. 2020;4(3):320-323doi: 10.1002/jgh3.12362.
Ling, K. L., Hilmi, I., Raja Ali, R. A., Leong, R. W. L., Leung, W. K., Ng, S. C., Wu, K. C., Chen, M. H., Ran, Z. H., Hisamatsu, T., Ahuja, V., Makharia, G. K., Banerjee, R., Wei, S. C., Wu, D. C., Pisespongsa, P., Ye, B. D., Sollano, J., Simadibrata, M., Chuah, S. W., & Ooi, C. J. (2020). Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic. JGH open : an open access journal of gastroenterology and hepatology, 4(3), 320-323. https://doi.org/10.1002/jgh3.12362
Ling, Khoon Lin, et al. "Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic." JGH open : an open access journal of gastroenterology and hepatology vol. 4,3 (2020): 320-323. doi: https://doi.org/10.1002/jgh3.12362
Ling KL, Hilmi I, Raja Ali RA, Leong RWL, Leung WK, Ng SC, Wu KC, Chen MH, Ran ZH, Hisamatsu T, Ahuja V, Makharia GK, Banerjee R, Wei SC, Wu DC, Pisespongsa P, Ye BD, Sollano J, Simadibrata M, Chuah SW, Ooi CJ. Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic. JGH Open. 2020 Jun 05;4(3):320-323. doi: 10.1002/jgh3.12362. eCollection 2020 Jun. PMID: 32514431; PMCID: PMC7273734.
Copy Download .nbib Format: NLM
Laser Acupuncture Effects on Speech and Social Interaction in Patients with Autism Spectrum Disorder.

Medical acupuncture

Surapaty IA, Simadibrata C, Rejeki ES, Mangunatmadja I.
PMID: 33101575
Med Acupunct. 2020 Oct 01;32(5):300-309. doi: 10.1089/acu.2020.1417. Epub 2020 Oct 19.

No abstract available.

Cite
Surapaty IA, Simadibrata C, Rejeki ES, et al. Laser Acupuncture Effects on Speech and Social Interaction in Patients with Autism Spectrum Disorder. Med Acupunct. 2020;32(5):300-309doi: 10.1089/acu.2020.1417.
Surapaty, I. A., Simadibrata, C., Rejeki, E. S., & Mangunatmadja, I. (2020). Laser Acupuncture Effects on Speech and Social Interaction in Patients with Autism Spectrum Disorder. Medical acupuncture, 32(5), 300-309. https://doi.org/10.1089/acu.2020.1417
Surapaty, Imtiaz Amrinusantara, et al. "Laser Acupuncture Effects on Speech and Social Interaction in Patients with Autism Spectrum Disorder." Medical acupuncture vol. 32,5 (2020): 300-309. doi: https://doi.org/10.1089/acu.2020.1417
Surapaty IA, Simadibrata C, Rejeki ES, Mangunatmadja I. Laser Acupuncture Effects on Speech and Social Interaction in Patients with Autism Spectrum Disorder. Med Acupunct. 2020 Oct 01;32(5):300-309. doi: 10.1089/acu.2020.1417. Epub 2020 Oct 19. PMID: 33101575; PMCID: PMC7583335.
Copy Download .nbib Format: NLM
Prognostic Value of COX-2, NF-κB, and Sp1 Tissue Expressions in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology

Renaldi K, Simadibrata M, Rahadiani N, Handjari DR, William A, Sinuraya F, Makmun D.
PMID: 34872897
Turk J Gastroenterol. 2021 Nov;32(11):956-970. doi: 10.5152/tjg.2021.211106.

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is deadly cancer with a poor prognosis. Molecular prognostic markers are needed to predict the patient's survival. The cyclooxygenase-2 enzyme (COX-2) and its 2 major transcription factors--nuclear factorkappa B (NF-κB) and specificity protein 1...

Cite
Renaldi K, Simadibrata M, Rahadiani N, et al. Prognostic Value of COX-2, NF-κB, and Sp1 Tissue Expressions in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis. Turk J Gastroenterol. 2021;32(11):956-970doi: 10.5152/tjg.2021.211106.
Renaldi, K., Simadibrata, M., Rahadiani, N., Handjari, D. R., William, A., Sinuraya, F., & Makmun, D. (2021). Prognostic Value of COX-2, NF-κB, and Sp1 Tissue Expressions in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 32(11), 956-970. https://doi.org/10.5152/tjg.2021.211106
Renaldi, Kaka, et al. "Prognostic Value of COX-2, NF-κB, and Sp1 Tissue Expressions in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis." The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology vol. 32,11 (2021): 956-970. doi: https://doi.org/10.5152/tjg.2021.211106
Renaldi K, Simadibrata M, Rahadiani N, Handjari DR, William A, Sinuraya F, Makmun D. Prognostic Value of COX-2, NF-κB, and Sp1 Tissue Expressions in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis. Turk J Gastroenterol. 2021 Nov;32(11):956-970. doi: 10.5152/tjg.2021.211106. PMID: 34872897.
Copy Download .nbib Format: NLM
Increased serum amylase and/or lipase in coronavirus disease 2019 (COVID-19) patients: Is it really pancreatic injury?.

JGH open : an open access journal of gastroenterology and hepatology

Pribadi RR, Simadibrata M.
PMID: 33553654
JGH Open. 2020 Dec 28;5(2):190-192. doi: 10.1002/jgh3.12436. eCollection 2021 Feb.

Coronavirus disease 2019 (COVID-19) is a novel disorder caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although it mainly affects the respiratory system, the pancreas could also become the virus' target. The issue regarding pancreatic involvement in COVID-19...

Cite
Pribadi RR, Simadibrata M. Increased serum amylase and/or lipase in coronavirus disease 2019 (COVID-19) patients: Is it really pancreatic injury?. JGH Open. 2020;5(2):190-192doi: 10.1002/jgh3.12436.
Pribadi, R. R., & Simadibrata, M. (2021). Increased serum amylase and/or lipase in coronavirus disease 2019 (COVID-19) patients: Is it really pancreatic injury?. JGH open : an open access journal of gastroenterology and hepatology, 5(2), 190-192. https://doi.org/10.1002/jgh3.12436
Pribadi, Rabbinu R, and Simadibrata, Marcellus. "Increased serum amylase and/or lipase in coronavirus disease 2019 (COVID-19) patients: Is it really pancreatic injury?." JGH open : an open access journal of gastroenterology and hepatology vol. 5,2 (2021): 190-192. doi: https://doi.org/10.1002/jgh3.12436
Pribadi RR, Simadibrata M. Increased serum amylase and/or lipase in coronavirus disease 2019 (COVID-19) patients: Is it really pancreatic injury?. JGH Open. 2020 Dec 28;5(2):190-192. doi: 10.1002/jgh3.12436. eCollection 2021 Feb. PMID: 33553654; PMCID: PMC7857272.
Copy Download .nbib Format: NLM
Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia.

Intestinal research

Ooi CJ, Hilmi I, Banerjee R, Chuah SW, Ng SC, Wei SC, Makharia GK, Pisespongsa P, Chen MH, Ran ZH, Ye BD, Park DI, Ling KL, Ong D, Ahuja V, Goh KL, Sollano J, Lim WC, Leung WK, Ali RAR, Wu DC, Ong E, Mustaffa N, Limsrivilai J, Hisamatsu T, Yang SK, Ouyang Q, Geary R, De Silva JH, Rerknimitr R, Simadibrata M, Abdullah M, Leong RW.
PMID: 31146509
Intest Res. 2019 Jul;17(3):285-310. doi: 10.5217/ir.2019.00026. Epub 2019 May 31.

The Asia-Pacific Working Group on inflammatory bowel disease (IBD) was established in Cebu, Philippines, under the auspices of the Asian Pacific Association of Gastroenterology with the goal of improving IBD care in Asia. This consensus is carried out in...

Cite
Ooi CJ, Hilmi I, Banerjee R, et al. Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia. Intest Res. 2019;17(3):285-310doi: 10.5217/ir.2019.00026.
Ooi, C. J., Hilmi, I., Banerjee, R., Chuah, S. W., Ng, S. C., Wei, S. C., Makharia, G. K., Pisespongsa, P., Chen, M. H., Ran, Z. H., Ye, B. D., Park, D. I., Ling, K. L., Ong, D., Ahuja, V., Goh, K. L., Sollano, J., Lim, W. C., Leung, W. K., Ali, R. A. R., Wu, D. C., Ong, E., Mustaffa, N., Limsrivilai, J., Hisamatsu, T., Yang, S. K., Ouyang, Q., Geary, R., De Silva, J. H., Rerknimitr, R., Simadibrata, M., Abdullah, M., Leong, R. W. (2019). Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia. Intestinal research, 17(3), 285-310. https://doi.org/10.5217/ir.2019.00026
Ooi, Choon Jin, et al. "Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia." Intestinal research vol. 17,3 (2019): 285-310. doi: https://doi.org/10.5217/ir.2019.00026
Ooi CJ, Hilmi I, Banerjee R, Chuah SW, Ng SC, Wei SC, Makharia GK, Pisespongsa P, Chen MH, Ran ZH, Ye BD, Park DI, Ling KL, Ong D, Ahuja V, Goh KL, Sollano J, Lim WC, Leung WK, Ali RAR, Wu DC, Ong E, Mustaffa N, Limsrivilai J, Hisamatsu T, Yang SK, Ouyang Q, Geary R, De Silva JH, Rerknimitr R, Simadibrata M, Abdullah M, Leong RW. Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia. Intest Res. 2019 Jul;17(3):285-310. doi: 10.5217/ir.2019.00026. Epub 2019 May 31. PMID: 31146509; PMCID: PMC6667368.
Copy Download .nbib Format: NLM
Effect of Electroacupuncture on Urea and Creatinine Levels in the Wistar Sepsis Model.

Medical acupuncture

Harpin D, Simadibrata CL, Mihardja H, Barasila AC.
PMID: 32104525
Med Acupunct. 2020 Feb 01;32(1):29-37. doi: 10.1089/acu.2019.1369. Epub 2020 Feb 03.

No abstract available.

Cite
Harpin D, Simadibrata CL, Mihardja H, et al. Effect of Electroacupuncture on Urea and Creatinine Levels in the Wistar Sepsis Model. Med Acupunct. 2020;32(1):29-37doi: 10.1089/acu.2019.1369.
Harpin, D., Simadibrata, C. L., Mihardja, H., & Barasila, A. C. (2020). Effect of Electroacupuncture on Urea and Creatinine Levels in the Wistar Sepsis Model. Medical acupuncture, 32(1), 29-37. https://doi.org/10.1089/acu.2019.1369
Harpin, Darwin, et al. "Effect of Electroacupuncture on Urea and Creatinine Levels in the Wistar Sepsis Model." Medical acupuncture vol. 32,1 (2020): 29-37. doi: https://doi.org/10.1089/acu.2019.1369
Harpin D, Simadibrata CL, Mihardja H, Barasila AC. Effect of Electroacupuncture on Urea and Creatinine Levels in the Wistar Sepsis Model. Med Acupunct. 2020 Feb 01;32(1):29-37. doi: 10.1089/acu.2019.1369. Epub 2020 Feb 03. PMID: 32104525; PMCID: PMC7041329.
Copy Download .nbib Format: NLM
Acupuncture Therapy in Post-Radiation Head-and-Neck Cancer with Dysgeusia.

Medical acupuncture

Djaali W, Simadibrata CL, Nareswari I.
PMID: 32595823
Med Acupunct. 2020 Jun 01;32(3):157-162. doi: 10.1089/acu.2020.1410. Epub 2020 Jun 16.

No abstract available.

Cite
Djaali W, Simadibrata CL, Nareswari I. Acupuncture Therapy in Post-Radiation Head-and-Neck Cancer with Dysgeusia. Med Acupunct. 2020;32(3):157-162doi: 10.1089/acu.2020.1410.
Djaali, W., Simadibrata, C. L., & Nareswari, I. (2020). Acupuncture Therapy in Post-Radiation Head-and-Neck Cancer with Dysgeusia. Medical acupuncture, 32(3), 157-162. https://doi.org/10.1089/acu.2020.1410
Djaali, Wahyuningsih, et al. "Acupuncture Therapy in Post-Radiation Head-and-Neck Cancer with Dysgeusia." Medical acupuncture vol. 32,3 (2020): 157-162. doi: https://doi.org/10.1089/acu.2020.1410
Djaali W, Simadibrata CL, Nareswari I. Acupuncture Therapy in Post-Radiation Head-and-Neck Cancer with Dysgeusia. Med Acupunct. 2020 Jun 01;32(3):157-162. doi: 10.1089/acu.2020.1410. Epub 2020 Jun 16. PMID: 32595823; PMCID: PMC7310235.
Copy Download .nbib Format: NLM
Electroacupuncture Enhances Number of Mature Oocytes and Fertility Rates for .

Medical acupuncture

Kusuma AC, Oktari N, Mihardja H, Srilestari A, Simadibrata CL, Hestiantoro A, Wiweko B, Muna N.
PMID: 31624528
Med Acupunct. 2019 Oct 01;31(5):289-297. doi: 10.1089/acu.2019.1368. Epub 2019 Oct 17.

No abstract available.

Cite
Kusuma AC, Oktari N, Mihardja H, et al. Electroacupuncture Enhances Number of Mature Oocytes and Fertility Rates for . Med Acupunct. 2019;31(5):289-297doi: 10.1089/acu.2019.1368.
Kusuma, A. C., Oktari, N., Mihardja, H., Srilestari, A., Simadibrata, C. L., Hestiantoro, A., Wiweko, B., & Muna, N. (2019). Electroacupuncture Enhances Number of Mature Oocytes and Fertility Rates for . Medical acupuncture, 31(5), 289-297. https://doi.org/10.1089/acu.2019.1368
Kusuma, Ayu Cintani, et al. "Electroacupuncture Enhances Number of Mature Oocytes and Fertility Rates for ." Medical acupuncture vol. 31,5 (2019): 289-297. doi: https://doi.org/10.1089/acu.2019.1368
Kusuma AC, Oktari N, Mihardja H, Srilestari A, Simadibrata CL, Hestiantoro A, Wiweko B, Muna N. Electroacupuncture Enhances Number of Mature Oocytes and Fertility Rates for . Med Acupunct. 2019 Oct 01;31(5):289-297. doi: 10.1089/acu.2019.1368. Epub 2019 Oct 17. PMID: 31624528; PMCID: PMC6795274.
Copy Download .nbib Format: NLM
The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases.

Intestinal research

Sanagapalli S, Ko Y, Kariyawasam V, Ng SC, Tang W, de Silva HJ, Chen M, Wu K, Aniwan S, Ng KK, Ong D, Ouyang Q, Hilmi I, Simadibrata M, Pisespongsa P, Gopikrishna S, Leong RW.
PMID: 30090040
Intest Res. 2018 Jul;16(3):409-415. doi: 10.5217/ir.2018.16.3.409. Epub 2018 Jul 27.

BACKGROUND/AIMS: To examine the association between use of oral contraceptive pills (OCPs) and the risk of developing inflammatory bowel diseases (IBD), in a modern cohort.METHODS: A prospective nested case-control study across sites in the Asia-Pacific region was conducted; involving...

Cite
Sanagapalli S, Ko Y, Kariyawasam V, et al. The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases. Intest Res. 2018;16(3):409-415doi: 10.5217/ir.2018.16.3.409.
Sanagapalli, S., Ko, Y., Kariyawasam, V., Ng, S. C., Tang, W., de Silva, H. J., Chen, M., Wu, K., Aniwan, S., Ng, K. K., Ong, D., Ouyang, Q., Hilmi, I., Simadibrata, M., Pisespongsa, P., Gopikrishna, S., Leong, R. W. (2018). The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases. Intestinal research, 16(3), 409-415. https://doi.org/10.5217/ir.2018.16.3.409
Sanagapalli, Santosh, et al. "The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases." Intestinal research vol. 16,3 (2018): 409-415. doi: https://doi.org/10.5217/ir.2018.16.3.409
Sanagapalli S, Ko Y, Kariyawasam V, Ng SC, Tang W, de Silva HJ, Chen M, Wu K, Aniwan S, Ng KK, Ong D, Ouyang Q, Hilmi I, Simadibrata M, Pisespongsa P, Gopikrishna S, Leong RW. The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases. Intest Res. 2018 Jul;16(3):409-415. doi: 10.5217/ir.2018.16.3.409. Epub 2018 Jul 27. PMID: 30090040; PMCID: PMC6077300.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 14 entries